ZINOVIYA PETRYSHYN: Open Payments
NPI 1417208364 · WEST ORANGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,497 in 127 payments from 21 companies in 2025. Trend: 2023 $1,745 · 2024 $2,655 · 2025 $2,497
Food & beverage: $2,409Education: $88
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $525 |
| Janssen Biotech, Inc. | 14 | $262 |
| Regeneron Healthcare Solutions, Inc. | 14 | $261 |
| GENZYME CORPORATION | 3 | $208 |
| PFIZER INC. | 11 | $177 |
| Arcutis Biotherapeutics, Inc. | 11 | $159 |
| Organon LLC | 3 | $146 |
| Botanix SB Inc | 6 | $110 |
| Lilly USA, LLC | 6 | $109 |
| UCB, Inc. | 5 | $87 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, RINVOQ, Zoryve, VTAMA, SOFDRA, CIBINQO.
Industry payments across NJ — which companies pay providers there.
